According to a news release from Guardant, however, Shield "is the first blood test to be approved by the FDA as a primary screening option for colorectal cancer, meaning healthcare providers can ...

The US Preventive Services Task Force recommends screening for cervical cancer with cervical cytology – also known as a Pap test or Pap smear – every three years for women ages 21 to 29. For ...

POMPANO BEACH, Fla., Aug. 28, 2024 /PRNewswire/ -- Oncosure, a leader in cancer diagnostics, is excited to introduce its groundbreaking Rapid Cancer Screening Test, making early detection ...

No single test is best for all people, so your doctor will tailor their approach. Screening may just be a casual face-to-face talk, or your doctor may use information from lab tests like liver ...

(CBS) -- The maker of an at-home cervical cancer screening test said Friday it has won approval from the Food and Drug Administration, giving patients an alternative to in-clinic pap smears.

Figures show cervical screening uptake is declining, with nearly a third of women in England – particularly younger women – not taking up their most recent test. Experts say women may refuse ...

Ever since, like many women, she has dreaded the cervical cancer screening test, which requires a patient’s legs to be held apart with stirrups and a cold metal device to be inserted vaginally ...

A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood ...

It is the first blood test approved by the FDA as a primary screening option for the cancer and the first blood test of its kind to meet the requirements for Medicare coverage, the company said in ...